Products

What will AGI do for Artemether?

This classification denotes an antimalarial agent with the molecular formula C16H26O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C7D6T3H22J, chemically known as 3,12-epoxy-12h-pyrano(4,3-j)-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-trimethyl-, (3-alpha,5a-beta,6-beta,8a-beta,9-alpha,12-beta,12ar)-, (+)- but generally known as artemether, which bears US NIH Compound Identifier 68911. European Medicines Agency schedules Artemether in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05574MIG. The term ARTEMETHER is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules artemether in its Anatomical Therapeutic Chemical (ATC) Classification. ARTEMETHER is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule artemether under HS 29329970 and SITC 51569. As of Q4 2014, ARTEMETHER remains the US FDA Preferred Term for this commodity. Artemether bears US NLM identifiers UMLS ID C0052429 and NCI Concept Code C73001. SMILES: O1OC2(OC3OC(OC)C(C4C13C(C(CC4)C)CC2)C)C.